Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MCD vs MRNA✓SelectedUSD · MRNAMCD vs MRNA performance historyLatest closeAs of+0.33%11/20
Stock and ETF performance explorer

MCD vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+5.3%
MRNA return
+153.9%
Excess return
-148.6%
Maximum drawdown
-31.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+0.3%-2.2%+2.5%+0.3%
7D+0.5%-12.7%+13.2%+0.5%
30D+11.0%-20.7%+31.6%+11.1%
3M+2.2%+46.3%-44.0%+2.1%
6M-1.1%+305.2%-306.4%-2.3%
YTD-8.8%+561.2%-570.1%-10.7%
1Y-7.9%+772.1%-779.9%-10.1%
3Y+5.3%+147.0%-141.7%+5.4%
All+5.3%+153.9%-148.6%+5.4%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling